FindTrial
Sign In

Studying the effectiveness of Iron Supplementation in women with Iron Deficiency Anemia

Effectiveness of Iron Supplementation on Consecutive Day versus Alternate Day in women with Iron Deficiency Anemia-A Randomized Comparative study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091080
Enrollment
120
Registered
2025-07-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

Intervention1: Ferrous Fumarate 156 mg OD with Folic Acid 1500 mcg OD: Group A- Consecutive day administered with Ferrous fumarate 156mg OD and Folic acid 1500 mcg OD, Group B Alternate day administer

Sponsors

SRM college of pharmacy
Lead Sponsor
Tamil Nadu Pharmaceutical Sciences Welfare Trust
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: ?Healthy women aged between 18-45 years with depleted iron stores (serum ferritin 25 ug/L or less) and haemoglobin levels (7-10.9 g/dl). ? Women with normal Body mass index (since overweight or obese women have sub clinical inflammation) ? Should not have donated blood or plasma donations in previous 4 months. ? Should not be on any medications that may interfere with iron absorption within two weeks of the study start.

Exclusion criteria

Exclusion criteria: 1. Women not willing to give the informed consent 2. Ferritin level > 40 ug/L 3. Any other chronic illness 4. Other causes of anaemic illness like Enlarged spleen (splenomegaly), Hemolysis, Porphyria., Sickle Cell Anaemia, Thalassemia

Design outcomes

Primary

MeasureTime frame
To assess whether alternate-day administration of iron supplement increases iron absorption compared to consecutive-day iron administration. Timepoint: At the end of 1st, 2nd and 3rd months—

Secondary

MeasureTime frame
To assess for the safety/tolerability of the iron supplementation in both the study groups.Timepoint: Correlate iron absorption with serum iron and iron status parameters at the end of the 1st, 2nd and 3rd months—

Countries

India

Contacts

Public ContactManikandan S

SRM College of Pharmacy

sarumats@srmist.edu.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026